ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $95 | -99.9% | 256,649 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $128,000 | -14.7% | 256,649 | 0.0% | 0.01% | -18.2% |
| Q2 2022 | $150,000 | -18.0% | 256,649 | 0.0% | 0.01% | -21.4% |
| Q1 2022 | $183,000 | -46.0% | 256,649 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $339,000 | -42.5% | 256,649 | 0.0% | 0.02% | -16.7% |
| Q3 2021 | $590,000 | -47.6% | 256,649 | 0.0% | 0.02% | -36.8% |
| Q2 2021 | $1,127,000 | -39.5% | 256,649 | 0.0% | 0.04% | -9.5% |
| Q1 2021 | $1,863,000 | +68.0% | 256,649 | 0.0% | 0.04% | +61.5% |
| Q4 2020 | $1,109,000 | +5.1% | 256,649 | 0.0% | 0.03% | -36.6% |
| Q3 2020 | $1,055,000 | -31.5% | 256,649 | 0.0% | 0.04% | -30.5% |
| Q2 2020 | $1,540,000 | -20.3% | 256,649 | 0.0% | 0.06% | -34.4% |
| Q1 2020 | $1,933,000 | -59.9% | 256,649 | -26.7% | 0.09% | -53.1% |
| Q4 2019 | $4,815,000 | -40.0% | 350,203 | -48.1% | 0.19% | -60.7% |
| Q3 2019 | $8,023,000 | -21.5% | 675,325 | -7.5% | 0.49% | -16.9% |
| Q2 2019 | $10,217,000 | -12.1% | 730,325 | +12.3% | 0.59% | -25.3% |
| Q1 2019 | $11,628,000 | +97.1% | 650,143 | +73.4% | 0.79% | +64.1% |
| Q4 2018 | $5,899,000 | – | 375,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |